RA CAPITAL MANAGEMENT, L.P.

BOSTON, MA · Quarter end: Sep 30, 2026 · Filed with SEC: Nov 16, 2026 · Open the SEC source ↗
Portfolio Return (1Y)——
Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.$9.97B2026 Q3
Positions92
Top-10 ConcentrationPercent of the portfolio in the 10 largest holdings. High means the fund is concentrated in few stocks.61.3%

RA CAPITAL MANAGEMENT, L.P. reported 92 positions worth $9.97B as of September 30, 2026 (13F filed November 16, 2026). Largest holding: ASND (23.5%). Biggest move: add FRNM ($230.2M).

10 / 92 positions shown
#SymbolCompanyValue ↓% Port.Shares1YYTDSince reported
▸ 1 ASNDAscendis Pharma A/S$2.34B23.50%10,281,496——+20.9%
▸ 2 PBLSParabilis Medicines$942.2M9.45%29,177,964——-13.8%
▸ 3 PCVXVaxcyte$652.9M6.55%11,474,599——+8.3%
▸ 4 RYTMRhythm Pharmaceuticals$634.8M6.37%6,666,837——+12.9%
▸ 5 EWTXEdgewise Therapeutics$340.7M3.42%8,392,730——+7.6%
▸ 6 TYRATyra Biosciences$266.8M2.68%12,198,625——-8.5%
▸ 7 FRNMFreenome$242.0M2.43%15,367,270——-33.9%
▸ 8 COAGHemab Therapeutics$240.8M2.42%7,808,627——+26.6%
▸ 9 NAMSNewAmsterdam Pharma Co$232.3M2.33%9,550,191——-20.0%
▸ 10 SEPNSepterna$215.3M2.16%5,502,858——+6.5%

Pro Feature

The remaining 82 positions with Pro.

Upgrade to Pro

Read the 2026-Q2 quarterly report · 13F Filing Calendar

🔔 Tell me when this fund files a new 13F

No account needed: in your inbox the morning it is published.

Frequently Asked Questions

What stocks does RA CAPITAL MANAGEMENT, L.P. hold as of Q3 2026?

RA CAPITAL MANAGEMENT, L.P. reported 92 positions worth $9.97B in its Q3 2026 13F filing. Largest positions: ASND (23.5%), PBLS (9.5%), PCVX (6.5%), RYTM (6.4%) and EWTX (3.4%).

What did RA CAPITAL MANAGEMENT, L.P. buy in Q3 2026?

New positions: AMLX, WVE, LTGO, OBX and DMRA (20 in all). Added to: FRNM, VOR, TSHA, CAPR and PBLS (7 in all).

What did RA CAPITAL MANAGEMENT, L.P. sell in Q3 2026?

Reduced: GHRS, ZLAB, SEPN, JBIO and SION (13 in all). Sold out entirely: BCRX, 96663EUR, NUVLEUR, NTLA and DFTX (12 in all).

13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.